Outcome of Multimodal Anesthesia Bern

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · May 19, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to manage pain during and after major surgery by using a method called multimodal anesthesia (MMA). Instead of relying heavily on opioids, which can have serious side effects and contribute to the ongoing opioid crisis, MMA combines several different techniques and medications to help control pain. This approach aims to improve recovery and reduce complications like nausea and other postoperative issues. The trial will compare the outcomes of patients receiving MMA with those getting traditional opioid-based anesthesia.

To participate in this study, you must be at least 18 years old, speak German, Italian, or French, and be scheduled for surgery lasting 60 minutes or more. You will also need to provide informed consent. However, if you are having a palliative surgery, are pregnant or breastfeeding, or have certain allergies, you may not be eligible. If you join the trial, you can expect to be part of a patient-centered approach that focuses on reducing pain and improving your overall recovery experience.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Existing informed consent
• • German, Italian or French speaking
• • Age 18 or more
• • Planned duration of surgery 60min or more
• • Inpatients and postoperative transfer to PACU or 24h ICU
• Exclusion Criteria:
• • Palliative or emergency procedures
• • Reoperation (e.g. 2nd look)
• • Bariatric surgery patients
• • Pregnancy / breastfeeding
• • Adults legally protected
• • Known allergy or contraindication to interventional medication